HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Inflammatory Bowel Disease 15

Networked: 4 relevant articles (0 outcomes, 2 trials/studies)

Disease Context: Research Results

Digestive System Diseases: 1042
- Gastrointestinal Diseases: 5874
  - Gastroenteritis: 4572
    - Inflammatory Bowel Diseases: 24316
      - Inflammatory Bowel Disease 15: 4
  - Intestinal Diseases: 1601
    - Inflammatory Bowel Diseases: 24316
      - Inflammatory Bowel Disease 15: 4

Related Diseases

1.	Crohn Disease (Crohn's Disease)
2.	Ulcerative Colitis
3.	Necrosis
4.	Body Weight (Weight, Body)
5.	Refractory Anemia

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Inflammatory Bowel Disease 15:

1.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/01/1993 - "This study determined the location and tissue density of cells immunoreactive for tumour necrosis factor alpha (TNF alpha) in intestinal specimens from 24 patients with chronic inflammatory bowel disease (15 with Crohn's disease, nine with ulcerative colitis) and 11 controls. "
2.	IronIBA 03/07/1996 - "Thirty-four patients with inflammatory bowel disease (15 with ulcerative colitis and 19 with Crohn's disease) and anemia refractory to iron therapy (hemoglobin concentrations below 10.0 g per deciliter [6.2 mmol per liter]) were randomly assigned in a prospective, double-blind, 12-week trial to receive either oral iron (100 mg per day) and subcutaneous erythropoietin (150 U per kilogram of body weight twice per week) (n=17) or oral iron and placebo (n=17). "
3.	Hemoglobins (Hemoglobin)IBA 03/07/1996 - "Thirty-four patients with inflammatory bowel disease (15 with ulcerative colitis and 19 with Crohn's disease) and anemia refractory to iron therapy (hemoglobin concentrations below 10.0 g per deciliter [6.2 mmol per liter]) were randomly assigned in a prospective, double-blind, 12-week trial to receive either oral iron (100 mg per day) and subcutaneous erythropoietin (150 U per kilogram of body weight twice per week) (n=17) or oral iron and placebo (n=17). "
4.	Erythropoietin FDA Link 03/07/1996 - "Thirty-four patients with inflammatory bowel disease (15 with ulcerative colitis and 19 with Crohn's disease) and anemia refractory to iron therapy (hemoglobin concentrations below 10.0 g per deciliter [6.2 mmol per liter]) were randomly assigned in a prospective, double-blind, 12-week trial to receive either oral iron (100 mg per day) and subcutaneous erythropoietin (150 U per kilogram of body weight twice per week) (n=17) or oral iron and placebo (n=17). "
5.	SteroidsIBA 07/01/1999 - "Twenty-three patients with severe and steroid-refractory inflammatory bowel disease (15 ulcerative colitis and 8 Crohn's disease) were included. "
6.	Radioisotopes (Radionuclides)IBA 08/01/1981 - "The distribution of autologous leucocytes labelled with the gamma-ray emitting radioisotope indium-111 was studied in 25 patients with inflammatory bowel disease, 15 with Crohn's disease, and 10 with ulcerative colitis. "
7.	Indium-111IBA 08/01/1981 - "The distribution of autologous leucocytes labelled with the gamma-ray emitting radioisotope indium-111 was studied in 25 patients with inflammatory bowel disease, 15 with Crohn's disease, and 10 with ulcerative colitis. "

Therapies and Procedures

1.

03/07/1996 - "Thirty-four patients with inflammatory bowel disease (15 with ulcerative colitis and 19 with Crohn's disease) and anemia refractory to iron therapy (hemoglobin concentrations below 10.0 g per deciliter [6.2 mmol per liter]) were randomly assigned in a prospective, double-blind, 12-week trial to receive either oral iron (100 mg per day) and subcutaneous erythropoietin (150 U per kilogram of body weight twice per week) (n=17) or oral iron and placebo (n=17). "